Pleasing Signs As A Number Of Insiders Buy Design Therapeutics Stock [Yahoo! Finance]
Design Therapeutics, Inc. (DSGN)
Company Research
Source: Yahoo! Finance
Design Therapeutics, Inc.'s NASDAQ:DSGN ) case, it's fantastic news for shareholders. Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. The Last 12 Months Of Insider Transactions At Design Therapeutics Over the last year, we can see that the biggest insider purchase was by Independent Director John Schmid for US$100k worth of shares, at about US$3.74 per share. Even though the purchase was made at a significantly lower price than the recent price (US$5.38), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. Design Therapeutics insiders may have bought shares in the last year, but they didn't sell any. They paid about US$3.12 on average. We don't deny that it is nice to see insiders buying stock in the company. However, you should keep
Show less
Read more
Impact Snapshot
Event Time:
DSGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSGN alerts
High impacting Design Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
DSGN
News
- Design Therapeutics to Participate in the 2024 Cantor Global Healthcare ConferenceGlobeNewswire
- Wall Street Analysts Think Design Therapeutics (DSGN) Could Surge 39.72%: Read This Before Placing a Bet [Yahoo! Finance]Yahoo! Finance
- With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors [Yahoo! Finance]Yahoo! Finance
- Design Therapeutics, Inc. (NASDAQ: DSGN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $4.00 price target on the stock.MarketBeat
- Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio [Yahoo! Finance]Yahoo! Finance
DSGN
Earnings
- 3/19/24 - Beat
DSGN
Sec Filings
- 8/13/24 - Form SC
- 8/12/24 - Form 4
- 8/9/24 - Form 144
- DSGN's page on the SEC website